Silymarin: An option to treat non-alcoholic fatty liver disease

22Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

Abstract

We have read with a great interest the review published by Singh et al , on the treatment options in alcoholic and non-alcoholic fatty liver disease, including various new targeted therapies that are currently under investigation. Recently, we described the health effects of the Mediterranean diet associated to an antioxidant complex rich in silymarin, to improve in overweight patients anthropometric parameters, glucose and lipid metabolism and intra-hepatic fat accumulation.

Cite

CITATION STYLE

APA

Colica, C., Boccuto, L., & Abenavoli, L. (2017). Silymarin: An option to treat non-alcoholic fatty liver disease. World Journal of Gastroenterology, 23(47), 8437–8438. https://doi.org/10.3748/wjg.v23.i47.8437

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free